Atlas Trials

A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants

Clinical trial NCT03062761 · COMPLETED

Trial details

NCT number
NCT03062761
Sponsor
Nutricia Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Growth
Start date
2017-04-27
Primary completion
2018-10-26
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.